Phase I, Open Label Drug-Drug Interaction Study in Healthy Volunteers to Evaluate the Effect of KALETRA (Lopinavir-Ritonavir) on GSK706769 Pharmacokinetics and to Evaluate the Pharmacokinetics of a New Oral Formulation of GSK706769.
Phase of Trial: Phase I
Latest Information Update: 24 Jul 2017
At a glance
- Drugs GSK 706769; Lopinavir/ritonavir
- Indications HIV infections; HIV-1 infections
- Focus Pharmacokinetics
- 22 Jun 2012 Actual patient number 17 added as reported by ClinicalTrials.gov.
- 18 Dec 2008 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
- 18 Dec 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.